The treatment increases the beneficial microbial groups, which include Roseburia, Faecalibacterium prausnitzii, and Akkermansia [19]
The Missed fee is a flashy headline, but heres what actually happened: Yes, Novo Nordisk allowed a Canadian patent related to semaglutide to lapse , after missing a $450 maintenance fee but this wasnt a billion-dollar blunder
While GLP-1 medications have shown effectiveness in weight loss and managing type 2 diabetes, they may not be suitable for everyone
Still, semaglutide is contraindicated in anyone with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) symptoms to watch for: a lump in your neck, hoarseness, or difficulty swallowing
Body size, baseline labs, what else you are taking, and what you are trying to accomplish all change the answer
Sue Stock, endocrinologist and co-founder of Lifespan Medical, for a practical, evidence-based discussion on how GLP-1s actually work, who they are appropriate for, and where they fit within a long-term approach to weight management and blood sugar control